Literature DB >> 6291539

The interaction of miconazole and ketoconazole with lipids.

H Van den Bossche, J M Ruysschaert, F Defrise-Quertain, G Willemsens, F Cornelissen, P Marichal, W Cools, J Van Cutsem.   

Abstract

Staphylococcus aureus can be protected by unsaturated unesterified fatty acids against the growth inhibitory effects of miconazole and ketoconazole observed at concentrations greater than 10(-6) M and greater than 10(-5) M, respectively. Miconazole's fungicidal activity is partly antagonized by oleic acid. However, the effect of ketoconazole on the viability of Candida albicans was not affected by this fatty acid. Cytochrome oxidase and ATPase activities are more sensitive to miconazole (10(-5) M) than to ketoconazole (greater than 10(-4) M) and also liposomes are more susceptible to lysis induced by miconazole. Using differential scanning calorimetry it is shown that high concentrations of miconazole shift the lipid transition temperature of multilamellar vesicles to lower values without affecting the enthalpy of melting. Ketoconazole induces a broadening of the main transition peak only. It is suggested that miconazole changes the lipid organization without binding to the lipids, whereas ketoconazole is localized in the multilayer without having an important direct effect on the lipid organization. The results indicate that miconazole, and to a lesser extent ketoconazole, at doses that can be reached by topical application only, interfere with a third target (the two others are ergosterol synthesis and fatty acid elongation plus desaturation). It is hypothesized that the induced change in lipid organization may play some role in miconazole's topical antibacterial and fungicidal activity, whereas it does not seem to play a significant role in ketoconazole's activities.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6291539     DOI: 10.1016/0006-2952(82)90707-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

1.  Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans.

Authors:  N D Lees; M C Broughton; D Sanglard; M Bard
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

Review 2.  Use of amphotericin B with azole antifungal drugs: what are we doing?

Authors:  A M Sugar
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

3.  Antiproliferative synergism of the allylamine SF 86-327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

Authors:  J A Urbina; K Lazardi; T Aguirre; M M Piras; R Piras
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

4.  A parenteral econazole formulation using a novel micelle-to-liposome transfer method: in vitro characterization and tumor growth delay in a breast cancer xenograft model.

Authors:  Sebastian Cogswell; Stuart Berger; Dawn Waterhouse; Marcel B Bally; Ellen K Wasan
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

5.  Correlation of carotenoid production, decreased membrane fluidity, and resistance to oleic acid killing in Staphylococcus aureus 18Z.

Authors:  N R Chamberlain; B G Mehrtens; Z Xiong; F A Kapral; J L Boardman; J I Rearick
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

6.  Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans.

Authors:  N H Georgopapadakou; B A Dix; S A Smith; J Freudenberger; P T Funke
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

7.  Ursodeoxycholic acid increases low-density lipoprotein binding, uptake and degradation in isolated hamster hepatocytes.

Authors:  B Bouscarel; H Fromm; S Ceryak; M M Cassidy
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

8.  Comparison of ketoconazole and amphotericin B in interference with thymidine uptake by and blastogenesis of lymphocytes stimulated with Histoplasma capsulatum antigens.

Authors:  R H Alford; B B Cartwright
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

9.  Anticandidal activities of terconazole, a broad-spectrum antimycotic.

Authors:  E L Tolman; D M Isaacson; M E Rosenthale; J L McGuire; J Van Cutsem; M Borgers; H Van den Bossche
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

10.  Sublethal injury and resuscitation of Candida albicans after amphotericin B treatment.

Authors:  Robert S Liao; Robert P Rennie; James A Talbot
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.